Yu Daohai, Ramsey Frederick V, Norton William F, Norton Nancy, Schneck Susan, Gaetano Tegan, Parkman Henry P
Department of Clinical Sciences, Temple Clinical Research Institute (TCRI), Temple University School of Medicine, Philadelphia, PA, USA.
International Foundation for Functional Gastrointestinal Disorders, Milwaukee, WI, USA.
Dig Dis Sci. 2017 Apr;62(4):879-893. doi: 10.1007/s10620-017-4456-7. Epub 2017 Jan 21.
The impact of gastroparesis on patients from the patient's viewpoint is needed to better address treatment priorities. The aims of this study were to: (1) Delineate burdens and concerns of patients with gastroparesis; (2) investigate specific symptoms contributing to impaired quality of life (QOL) in gastroparesis.
The International Foundation for Functional GI Disorders gastroparesis survey questionnaire was developed to describe patients' viewpoint about their experience with gastroparesis and included Patient Assessment of Upper GI Symptoms (PAGI-SYM) and SF-36 QOL survey.
A total of 1423 adult patients with gastroparesis completed the survey. Average duration of gastroparesis symptoms was 9.3 years with time from onset to diagnosis 5.0 years. Patients felt that they receive good information regarding treatment options from physicians, the Internet, and Facebook. Patients rated their satisfaction with available treatment for their gastroparesis as dissatisfied (33%), somewhat dissatisfied (27%), neutral (14%), somewhat satisfied (15%), and satisfied (4%). Patients felt that gastroparesis symptoms that are most important to improve with treatment are nausea, stomach pain, and vomiting. Overall, there was a decreased quality of life by SF-36. Physical health QOL score was negatively correlated with symptoms including nausea (r = -0.37), upper abdominal pain (r = -0.37), and early satiety (r = -0.37).
This large series of patients with gastroparesis describes their burdens, concerns, and QOL. Nausea, vomiting, early satiety, and abdominal pain are important symptoms for treatment. Many patients are not satisfied with current treatments, wanting specific treatments for their disorder. Interestingly, a large number of patients find out about treatments, not only from their physician, but also using the Internet including social media.
从患者角度了解胃轻瘫对患者的影响,以便更好地确定治疗重点。本研究的目的是:(1)描述胃轻瘫患者的负担和担忧;(2)调查导致胃轻瘫患者生活质量受损的具体症状。
制定了国际功能性胃肠病基金会胃轻瘫调查问卷,以描述患者对胃轻瘫经历的看法,包括上消化道症状患者评估(PAGI-SYM)和SF-36生活质量调查问卷。
共有1423例成年胃轻瘫患者完成了调查。胃轻瘫症状的平均持续时间为9.3年,从发病到诊断的时间为5.0年。患者认为他们从医生、互联网和脸书上获得了有关治疗选择的良好信息。患者对现有胃轻瘫治疗的满意度为不满意(33%)、有点不满意(27%)、中立(14%)、有点满意(15%)和满意(4%)。患者认为治疗中最需要改善的胃轻瘫症状是恶心、胃痛和呕吐。总体而言,SF-36显示生活质量下降。身体健康生活质量得分与恶心(r = -0.37)、上腹部疼痛(r = -0.37)和早饱(r = -0.37)等症状呈负相关。
这一大系列胃轻瘫患者描述了他们的负担、担忧和生活质量。恶心、呕吐、早饱和腹痛是重要的治疗症状。许多患者对当前治疗不满意,希望针对其疾病进行特定治疗。有趣的是,大量患者不仅从医生那里,还通过包括社交媒体在内的互联网了解治疗方法。